United States Pharmacopeia holds an Expert Panel Discussion on the Role of Medicines to Curb Antimicrobial Resistance
Participants: Ms. Rocio Alatorre Eden-WynterCommissioner of Evidence and Risk Management, COFEPRIS.Ms. Delese Mimi DarkoChief Executive Officer, Food and Drugs Authority, Ghana.Dr. Hajime InoueSenior Advisor to the Director-General and Special Representative for AntimicrobialResistance, World Health Organization.Dr. Larry KerrDirector, Pandemics and Emerging Threats Office, Office of Global Affairs,U.S. Department of Health and Human Services.Ms. Irene KoekActing Assistant Administrator, U.S. Agency for International Development.Dr. Ramanan Laxminarayan (Moderator)Director and Senior Fellow, Center for Disease Dynamics, Economics & PolicySenior Research Scholar and Lecturer, Princeton Environmental Institute at PrincetonUniversity.Mr. Mirfin MpunduHead, ReAct AfricaExecutive Director, Ecumenical Pharmaceutical Network.Mr. Jude NwokikeDirector, Promoting the Quality of Medicines (PQM) Program, USP.Dr. Ronald PiervincenziChief Executive Officer, USPProfessor Akmal TaherSpecial Advisor, Minister of Health, Republic of Indonesia.
Time: 4:30 am EDT, Date: Tuesday, September 19th, 2017
You must be a Subscriber to read the full transcript.
Subscribing has benefits:
- Unlimited access to our transcripts database of over 220,000 transcripts.
- First access to current transcripted events, even while they are being transcribed.
- Direct email alerts detailing our coverage schedule so you can plan ahead.